147
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Molecular characterization and therapeutic reaction to dasatinib in a CML patient harboring a novel e8a2 BCR-ABL1 transcript with a somatic mutation in TP53BP2 and cadherin-10 genes

, , , , &
Pages 233-236 | Received 28 Dec 2016, Accepted 19 Apr 2017, Published online: 30 May 2017
 

Acknowledgements

The authors would like to thank the patient and related control-individuals for participation in this study. This work was supported in part by the National Natural Science Foundation of China (No. 81500171).

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2017.1323269

Additional information

Funding

This work was supported in part by the National Natural Science Foundation of China (No. 81500171).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.